多omics分析确定OSGEPL1是肝细胞癌中的瘤基因
Sintim Mui1,2, Juanyi Shi1,3, Kai Wen1,2
1Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Discover oncology
|March 17, 2025
概括
调节失调的N6-Threonylcarbamoyladenosine (t6A) 修饰,特别是OSGEPL1,与肝细胞癌 (HCC) 的进展有关. 上调的OSGEPL1恶化了预后,并促进了HCC细胞的生长,这表明它是治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 修饰N6-Threonylcarbamoyladenosine (t6A) 基因及其相关基因与各种癌症有关,包括肝细胞癌 (HCC).
- 通过t6一个修改影响HCC病变的精确机制尚未完全理解.
- 在这种途径中识别关键基因可能会揭示HCC的新型治疗点.
研究的目的:
- 调查t6A修饰途径基因,特别是OSGEPL1在肝细胞癌 (HCC) 中的作用.
- 分析OSGEPL1表达和临床结果,瘤特征和HCC中的免疫透之间的相关性.
- 探索OSGEPL1作为HCC治疗的潜在治疗点.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库对HCC中t6A相关基因进行全面分析.
- 检查了基因表达,生存结果,功能丰富,免疫细胞透和体质突变数据.
- 进行了体外实验,以验证OSGEPL1在HCC细胞增殖中的作用.
主要成果:
- 发现OSGEPL1在HCC组织上升调节,与瘤等级,病理T阶段和整体阶段相关.
- 增加OSGEPL1表达与HCC患者的整体存活率降低和免疫细胞透率降低有关.
- 实验室研究证实,OSGEPL1促进了HCC细胞的增殖.
结论:
- 调节失调的t6A修改路径,由高OSGEPL1证明,与HCC预后有显著的关联.
- OSGEPL1成为潜在的预后生物标志物和肝细胞癌的治疗标.
- 这些发现为HCC病原体和未来治疗策略的潜在途径提供了新的见解.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Genomics
35.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.6K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


